Clinical Trial Update: Moyamoya Disease Biomarkers in Patients With Intracranial Atherosclerotic Stroke

View source ↗

Summary

A clinical trial update evaluating biomarkers in Moyamoya disease among patients with intracranial atherosclerotic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Arterial Stenosis
• Intracranial Atherosclerotic Disease
• Moyamoya Disease

Snippet

Sponsor: Samsung Medical Center | Conditions: Moyamoya Disease, Intracranial Atherosclerotic Stroke | Status: UNKNOWN